Table: begin end state 1 16 cytoplasmic 17 41 transmembrane 42 54 non-cytoplasmic 55 76 transmembrane 77 83 cytoplasmic 84 104 transmembrane 105 110 non-cytoplasmic 111 130 transmembrane 131 141 cytoplasmic 142 166 transmembrane 167 171 non-cytoplasmic 172 193 transmembrane 194 253 cytoplasmic 254 274 transmembrane 275 288 non-cytoplasmic 289 309 transmembrane 310 315 cytoplasmic 316 334 transmembrane 335 339 non-cytoplasmic 340 357 transmembrane 358 377 cytoplasmic 378 400 transmembrane 401 407 non-cytoplasmic 408 427 transmembrane 428 446 cytoplasmic
Input: >RR42_RS21935 MDVQQFIDSQPFSRFQWIILILCFLIVAADGFDTAAIGFIAPMLAKEWGVSRAHLGPVMS AALFGLAAGALVAGPLADRFGRKGVLVGSVLCFGGWSVASAFASSLEALTVLRFLTGLGL GAAMPNAVTLMSEYAPTRRRSLAVNAMFCGFTLGSSAGGFAAAWLIPHYGWHSVLLVGGV APLLLAVLLILFLPESVRFLVARKAPDARIAAALSKVHPGVLRADERFHVQEAAPTGASS LRTILMPQFRSGTVLLWTTYFMGLLIFYLLTSWLPTLFADAGYPIEKAALITALFPLGGG IGTLTVGWLMDRGHPWRIVAGTYALTGALVYAVGHGAGDVFLLGVLVFAAGTCMNGAQSS MPTLAAGFYPTQCRATGVAWMLGIGRFGGIAGALLGAQILGLGWSFGKIFGLLSLPAFVA TAALLIASARPRAAVRPAVGQHDAAH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server